top of page

Future Events

  • Targeting an endogenous retrovirus as a therapeutic approach to ALS
    Targeting an endogenous retrovirus as a therapeutic approach to ALS
    Targeting an endogenous retrovirus as a therapeutic approach to ALS
    Wed, Jan 08
    Virtual Zoom Event
    Jan 08, 2025, 7:00 PM EST
    Virtual Zoom Event
    Jan 08, 2025, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research. Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial
  • Three Molecular Subtypes of ALS: Stress, Inflammation, and TDP-43 pathology
    Three Molecular Subtypes of ALS: Stress, Inflammation, and TDP-43 pathology
    Three Molecular Subtypes of ALS: Stress, Inflammation, and TDP-43 pathology
    Wed, Jan 22
    Virtual Zoom Event
    Jan 22, 2025, 7:00 PM EST
    Virtual Zoom Event
    Jan 22, 2025, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research. Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial
  • ALS Studies, Trials, and Treatments - AMP ALS
    ALS Studies, Trials, and Treatments - AMP ALS
    ALS Studies, Trials, and Treatments - AMP ALS
    Wed, Feb 05
    Virtual Zoom Event
    Feb 05, 2025, 7:00 PM EST
    Virtual Zoom Event
    Feb 05, 2025, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research. Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial
  • ALS Studies, Trials, and Treatments with Dr. Laura P. W. Ranum
    ALS Studies, Trials, and Treatments with Dr. Laura P. W. Ranum
    ALS Studies, Trials, and Treatments with Dr. Laura P. W. Ranum
    Wed, Feb 19
    Virtual Zoom Event
    Feb 19, 2025, 7:00 PM EST
    Virtual Zoom Event
    Feb 19, 2025, 7:00 PM EST
    Virtual Zoom Event
    Join us for an inspiring and informative event as we explore the remarkable journeys of individuals committed to advancing ALS research. Shifting the PARADIGM: PrimeC, an Oral Candidate for ALS, Demonstrates Safety, Efficacy, and Target Engagement Biomarkers in a Phase 2b Trial
bottom of page